Health

Amgen is standing behind a rare disease drug that the FDA wants off the market due to safety concerns and alleged clinical trial manipulation, and its defense will include a …

A new report from the Office of Inspector General revealed that the three largest Medicare Advantage insurers denied prior authorization requests for long-term acute care and inpatient rehabilitation at high …

Apparently, it’s not just me. I’m probably like most buyers of products or services, especially those in high tech. Watching a video of some other person using or demonstrating a …

Approximately two million new cancer cases are diagnosed in the United States each year. One of the most important aspects of cancer care for many patients won’t be a breakthrough …

Clinical AI startup Abridge is one of the most well-funded health tech startups in the nation, having raised $1.1 billion since its founding in 2018. On Thursday, the startup held …

A little over a week after CMS announced significant changes to Medicaid work requirements set to take effect in January 2027, healthcare leaders speaking at AHIP 2026 raised concerns about …

A Novartis RNA therapy reduced blood levels of a protein that’s a biological indicator of a particular form of muscular dystrophy, clinical trial results that could support an application seeking …

Value-based care (VBC) goals include better outcomes and sustainable reimbursement. But it won’t work if organizations can’t accurately attribute patients, providers, and encounters across an increasingly complex ecosystem. Many healthcare …

If you want to know where healthcare finance is headed, ask the people who lend hospitals money.  During a Tuesday panel at the HFMA Annual Conference in National Harbor, Maryland, …

The Digital Medicine Society (DiMe) unveiled a new initiative on Tuesday during the AHIP 2026 Conference that aims to create best practices for contracting with virtual care providers. DiMe is …